MeVis Medical Solutions AG

AI solutions promoting early lung cancer detection and treatment.

Company Overview

MeVis aims to contribute to the early detection and diagnostics of cancer, thus facilitating an early and tailored treatment of the disease. In order to meet this challenge, MeVis develops innovative software for the analysis and processing of image data.

From the beginning of a product idea, via the development of an application and their integration into customer specific platforms to the point of effective quality assurance, MeVis accompany their industrial customers.

Their clinical focus is the image-based early detection and diagnostics of epidemiologically significant conditions such as breast, lung, liver, prostate and intestinal cancer as well as neurological diseases. Furthermore, they provide technical visualizations for professional education, publication, presentation, and research.

MeVIs

Modalities

MRI-icon-2-150x150

Subspecialities

Thoracic icon

Applications available

MeVIs

Veolity™ LungCAD

Computer-aided detection (CAD) for solid pulmonary nodules for chest CT scans in lung cancer diagnostics.

CE

FDA

CT

Pulmonology

Oncology

To find out more about MeVis’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting